Compression Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Product (Compression Bandages, Compression Wraps, Compression Stockings {Class I, Class II, Class III}, Compression Tapes, Compression Pumps, Compression Braces, Others), By Technique (Static Compression Therapy, Dynamic Compression Therapy), By Application (Varicose Vein Treatment, Deep Vein Thrombosis Therapy, Lymphedema Treatment, Leg Ulcer Treatment, Others), By Distribution Channel (Pharmacies & Retails, Hospitals & Clinics, E-commers Platform, Home Care Settings), By Region and Competition, 2020-2030F

Market Overview

Global Compression Therapy Market was valued at USD 4.28 billion in 2024 and is expected to reach USD 5.34 billion by 2030 with a CAGR of 3.76% during the forecast period. The Market is projected to witness impressive growth during the forecast period. One significant factor is the increase in the frequency of vein problems like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots. The global compression therapy market is expanding as more products, particularly stockings and bandages, are employed to treat illnesses.

Compression therapy can be delivered through various types of products, including compression stockings, bandages, wraps, sleeves, pumps, and garments, among others. Global compression therapy market is driven by the increasing prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases that are associated with venous disorders, as well as an aging population. The rising prevalence of chronic diseases has led to an increased incidence of venous disorders such as deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and venous leg ulcers. Compression therapy is recognized as an effective non-invasive treatment option for managing these conditions, thereby driving the demand for compression therapy products, thereby supporting the growth of global compression therapy. Additionally, the growing awareness on the benefits of compression therapy in the management of lymphatic and venous disorders, advancements in compression therapy technologies, and the availability of a wide range of compression therapy products for different body parts and conditions are factors driving the market growth. Benefits Associated with Compression Therapy

Key Market Drivers

Rising Prevalence of Venous Disorders and Chronic Wounds

The increasing global burden of venous and lymphatic disorders is a primary driver for the compression therapy market. Conditions such as chronic venous insufficiency (CVI), deep vein thrombosis (DVT), and lymphedema are becoming more prevalent due to aging populations, sedentary lifestyles, and obesity. Compression therapy is a cornerstone in the management of these conditions, as it helps improve venous return, reduces swelling, and facilitates healing.

According to the U.S. Centers for Disease Control and Prevention (CDC), an estimated 900,000 people are affected by DVT or pulmonary embolism (PE) in the United States each year, with approximately 60,000–100,000 related deaths. The World Health Organization (WHO) has also reported that the global prevalence of chronic wounds, including diabetic foot ulcers and venous leg ulcers, is on the rise—particularly in aging populations and those with diabetes. Compression bandages, stockings, and other garments are widely recommended in clinical guidelines for the treatment of venous leg ulcers and post-thrombotic syndrome.

As these disorders continue to strain healthcare systems, the need for non-invasive, effective solutions like compression therapy has intensified. Governments are increasingly acknowledging the importance of early intervention in managing chronic wounds and venous diseases. For example, the UK's National Health Service (NHS) includes compression therapy in its wound care management protocols, and many insurance programs in the U.S. now reimburse for compression products under durable medical equipment (DME) categories. The cumulative effect of growing patient populations, supportive healthcare policies, and clinical efficacy is strongly driving the expansion of this market.

Increasing Geriatric Population and Associated Mobility Issues

The global demographic shift toward an aging population is another significant factor driving growth in the compression therapy market. Older adults are more susceptible to venous disorders, chronic leg ulcers, and lymphedema due to reduced vascular elasticity, prolonged immobility, and age-related health conditions. Compression therapy offers an effective, minimally invasive option to improve blood circulation, manage swelling, and support wound healing in this demographic.

According to the United Nations Department of Economic and Social Affairs (UN DESA), the number of people aged 65 years or older worldwide is projected to more than double by 2050, rising from 761 million in 2021 to over 1.6 billion. This population cohort is at elevated risk for chronic diseases, including cardiovascular conditions and diabetes, which are leading causes of venous complications. Furthermore, many elderly individuals experience reduced mobility due to arthritis, surgery recovery, or general frailty, all of which increase the likelihood of venous pooling and edema—conditions that are managed effectively with compression therapy.

Healthcare systems across the globe are responding to these demographic pressures. For instance, the European Union has implemented active aging and healthcare accessibility strategies that prioritize cost-effective treatments such as compression garments. Similarly, the U.S. Medicare program provides coverage for certain compression products prescribed for chronic venous insufficiency and lymphedema, reflecting institutional support for this therapy modality. As the global senior population continues to grow, so too will the demand for compression therapy products designed to enhance mobility and improve quality of life for aging patients.

Download Free Sample Report

Key Market Challenges

Lack of Awareness and Underutilization in Low- and Middle-Income Countries

Despite the clinical efficacy of compression therapy, its adoption remains limited in many low- and middle-income countries (LMICs) due to a lack of awareness among both healthcare providers and patients. In many regions, venous and lymphatic diseases are misdiagnosed or undertreated, and compression therapy is often under prescribed despite being a cost-effective solution. According to the World Bank and WHO, over 50% of the world’s population lacks access to essential health services, particularly in rural and underserved areas. In these regions, the focus of healthcare systems tends to be on acute and infectious diseases rather than chronic wounds and vascular care. Furthermore, educational programs for healthcare workers in LMICs often do not include sufficient training in wound management or vascular medicine, leading to underutilization of proven therapies like compression.

Moreover, cultural and socioeconomic barriers may prevent patients from using compression garments. For example, some patients find the products uncomfortable or unaffordable, especially when not covered by insurance. In India and Sub-Saharan Africa, studies have shown that less than 30% of patients with venous leg ulcers receive compression therapy as part of their treatment plan. Governments in these regions have begun to recognize the economic burden of chronic wounds, but substantial investments in education, awareness campaigns, and subsidized access to compression therapy are still needed to drive equitable usage across all income levels.

Compliance and Product Adherence Issues

Another major challenge for the compression therapy market is patient non-compliance, which significantly undermines the effectiveness of treatment. Compression therapy, especially in the form of stockings or multilayer bandages, requires consistent and correct use. However, many patients struggle with adherence due to discomfort, difficulty in application, or lack of immediate symptom relief.

Research published by the National Institutes of Health (NIH) indicates that adherence rates to compression stocking use among patients with venous ulcers are often below 50%. Factors contributing to this low compliance include the tightness of the garments, heat buildup during wear, skin irritation, and difficulty putting them on—particularly for elderly or disabled individuals. Additionally, patients with cognitive decline or arthritis may not be physically capable of donning or doffing these garments independently.

Governments and health agencies recognize that poor adherence contributes to prolonged wound healing, recurrent hospitalizations, and increased healthcare costs. For example, the UK’s National Health Service (NHS) has launched several initiatives focused on patient education and nurse-led interventions to improve compliance among those using compression therapy. Some insurance programs now also offer coverage for donning aids to support better product usage. Nevertheless, until manufacturers develop more user-friendly designs and healthcare providers invest in consistent patient education and follow-up, adherence will remain a significant barrier to optimal outcomes—limiting the broader impact of compression therapy on public health.

Key Market Trends

Integration of Smart Textiles and Wearable Technology

The fusion of compression therapy with smart textile technology is emerging as a transformative trend in the market. Smart compression garments embedded with sensors, microprocessors, and wireless connectivity offer real-time monitoring of pressure levels, limb circumference, and patient activity. These innovations not only enhance treatment efficacy but also improve patient compliance through personalized feedback and digital engagement.

For example, researchers funded by the European Commission’s Horizon 2020 program have been developing e-textiles that adjust compression dynamically in response to physiological changes. These systems are particularly useful for lymphedema patients whose limb swelling can fluctuate throughout the day. Additionally, connected compression wraps and sleeves are being trialed in clinical settings in the United States and Europe to monitor therapy adherence and wound healing progression. This data can be transmitted directly to healthcare providers, allowing for early interventions and tailored treatment adjustments.

Governments and funding agencies are actively supporting these technological advancements. In 2022, the U.S. National Science Foundation (NSF) awarded over $10 million in grants for research in wearable health monitoring technologies, a portion of which is focused on chronic condition management. Similarly, Japan’s Ministry of Economy, Trade and Industry (METI) is promoting medical IoT innovations under its Health and Medical Strategy. As smart healthcare ecosystems continue to evolve, the integration of compression therapy with wearable technologies is poised to redefine patient-centered care—shifting treatment from reactive wound management to proactive vascular health optimization.

Growing Emphasis on Home-Based and Outpatient Compression Solutions

The global healthcare landscape is shifting towards decentralized care models, and this trend is significantly influencing the compression therapy market. Increasing healthcare costs, hospital overcrowding, and the demand for patient convenience are prompting both providers and payers to promote home-based treatment options. As a result, compression therapy products designed for self-application are seeing growing adoption. The COVID-19 pandemic further accelerated this trend, as patients sought alternatives to in-clinic wound care. In response, manufacturers and healthcare systems have been developing user-friendly compression products that enable remote therapy with minimal supervision. Adjustable wraps, Velcro-based garments, and pneumatic compression devices with pre-set programs have gained popularity among patients managing venous ulcers or lymphedema at home.

Governments are actively encouraging the use of home-based care solutions. In the European Union, funding under the EU4Health program includes support for digital platforms that facilitate telemonitoring of chronic disease therapies, including compression therapy. The combination of cost efficiency, increased patient satisfaction, and favorable reimbursement policies is driving this trend forward. Moving ahead, the development of training tools, virtual assistance, and self-monitoring apps will further empower patients to manage their conditions at home making compression therapy more accessible and effective on a global scale.

Segmental Insights

Product Insights

Based on Product, Compression Bandages currently hold the largest market share in the Global Compression Therapy Market. These products are widely adopted across hospitals, outpatient clinics, and home healthcare settings due to their broad clinical applications and cost-effectiveness. Compression bandages are considered a first-line therapy in the treatment of venous leg ulcers, lymphedema, and post-surgical swelling. Their adaptability, ease of use, and ability to provide graduated compression make them a preferred choice among healthcare providers. According to the National Health Service (NHS) in the UK, compression bandaging is the gold standard treatment for venous leg ulcers, which account for more than 70% of all chronic leg ulcers. These ulcers significantly burden healthcare systems, with the NHS spending nearly £1 billion annually on their management — a portion of which is allocated to compression bandaging. Given their integral role in both acute and chronic care settings, compression bandages are widely used across developed and developing regions, contributing to their large market share.

Download Free Sample Report

Regional Insights

Based on the region, North America held the largest market share in the Global Compression Therapy Market. This dominance is attributed to the high prevalence of chronic venous disorders, lymphedema, and deep vein thrombosis (DVT) in the region, combined with a well-established healthcare infrastructure. The United States sees a significant number of cases of venous thromboembolism annually. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 900,000 Americans are affected by DVT or pulmonary embolism (PE) each year, with up to 100,000 deaths related to these conditions. Compression therapy is a frontline intervention in both treatment and prevention of these complications.

Furthermore, North America benefits from high public and private healthcare spending, favorable reimbursement frameworks, and strong awareness among healthcare professionals and patients regarding the benefits of compression therapy. In addition, the presence of major industry players, continuous product innovation, and active research initiatives—such as the development of smart compression garments and advanced pneumatic devices—have further supported market growth in the region. The region’s aging population and the rising incidence of obesity and sedentary lifestyles have also contributed to higher demand for compression solutions.

Recent Developments

• In November 2024, Cardinal Health introduced the Kendall SCD SmartFlow Compression System, an advanced device engineered to improve the prevention of venous thromboembolism (VTE) in hospitalized patients. This system delivers sequential compression therapy aimed at significantly lowering the risk of deep vein thrombosis (DVT) and pulmonary embolism by enhancing blood circulation in immobile or post-surgical individuals.
• In November 2024, researchers from the University of Edinburgh in Scotland unveiled an innovative, cost-effective device designed to prevent blood clots in patients at high risk, especially following surgery. The device is a flexible, polymer-based sensor placed under bandages or compression stockings and utilizes a handheld scanner to assess whether the applied pressure is optimal. This development marks a breakthrough in ensuring effective compression in post-operative care, especially for DVT prevention.
• In October 2024, Tactile Medical launched the next-generation Nimbl Pneumatic Compression Platform, tailored to improve the management of lymphedema, a chronic condition marked by swelling due to lymphatic blockage, often in the limbs. The updated platform provides enhanced therapeutic features that prioritize comfort, convenience, and efficacy, offering a more patient-friendly solution for long-term lymphedema care.

Key Market Players

• Cardinal Health
• Medtronic plc
• Koninklijke Philips N.V.
• Siemens Healthineers
• GE Healthcare
• FUJIFILM SonoSite, Inc.
• Natus Medical Incorporated
• Huntleigh Healthcare Ltd
• The Cooper Companies
• CONTEC MEDICAL SYSTEMS CO., LTD

Report Scope:

In this report, the Global Compression Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Compression Therapy Market, By Product:

o   Compression Bandages

o   Compression Wraps

o   Compression Stockings (Class I, Class II, Class III)

o   Compression Tapes

o   Compression Pumps

o   Compression Braces

o   Others

• Compression Therapy Market, By Technique:

o   Static Compression Therapy

o   Dynamic Compression Therapy

• Compression Therapy Market, By Application:

o   Varicose Vein Treatment

o   Deep Vein Thrombosis Therapy

o   Lymphedema Treatment

o   Leg Ulcer Treatment

o   Others

• Compression Therapy Market, By Distribution Channel:

o   Pharmacies & Retails

o   Hospitals & Clinics

o   E-commers Platform

o   Home Care Settings

• Compression Therapy Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Compression Therapy Market.

Available Customizations:

Global Compression Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Compression Therapy Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]